F. Lin and H. Worman, Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C, J Biol Chem. 5 août, vol.268, issue.22, pp.16321-16326, 1993.

H. Bécane, G. Bonne, S. Varnous, A. Muchir, V. Ortega et al., High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation, Pacing and Clinical Electrophysiology, vol.23, issue.11, pp.1661-1666, 2000.
DOI : 10.1046/j.1460-9592.2000.01661.x

M. Pasotti, C. Klersy, A. Pilotto, N. Marziliano, C. Rapezzi et al., Long-Term Outcome and Risk Stratification in Dilated Cardiolaminopathies, Journal of the American College of Cardiology, vol.52, issue.15, pp.1250-1260, 2008.
DOI : 10.1016/j.jacc.2008.06.044

J. Van-berlo, W. De-voogt, A. Van-der-kooi, J. Van-tintelen, G. Bonne et al., Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?, Journal of Molecular Medicine, vol.40, issue.1, pp.79-83, 2005.
DOI : 10.1007/s00109-004-0589-1

M. Taylor, P. Fain, G. Sinagra, M. Robinson, A. Robertson et al., Natural history of dilated cardiomyopathy due to lamin A/C gene mutations, Journal of the American College of Cardiology, vol.41, issue.5, pp.771-780, 2003.
DOI : 10.1016/S0735-1097(02)02954-6

C. Meune, V. Berlo, J. Anselme, F. Bonne, G. Pinto et al., Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations, New England Journal of Medicine, vol.354, issue.2, pp.209-210, 2006.
DOI : 10.1056/NEJMc052632

H. Cao and R. Hegele, Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy, Human Molecular Genetics, vol.9, issue.1, pp.109-112, 2000.
DOI : 10.1093/hmg/9.1.109

L. Dour, C. Schneebeli, S. Bakiri, F. Darcel, F. Jacquemont et al., A Homozygous Mutation of Prelamin-A Preventing Its Farnesylation and Maturation Leads to a Severe Lipodystrophic Phenotype: New Insights into the Pathogenicity of Nonfarnesylated Prelamin-A, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.5, pp.856-862, 2011.
DOI : 10.1210/jc.2010-2234

G. Bonne, D. Barletta, M. Varnous, S. Bécane, H. Hammouda et al., Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy, Nature Genetics, vol.21, issue.3, pp.285-288, 1999.
DOI : 10.1038/6799

D. Fatkin, C. Macrae, T. Sasaki, M. Wolff, M. Porcu et al., Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease, New England Journal of Medicine, vol.341, issue.23, pp.1715-1724, 1999.
DOI : 10.1056/NEJM199912023412302

A. Muchir, G. Bonne, A. Van-der-kooi, M. Van-meegen, F. Baas et al., Identification of mutations in the gene encoding lamins A, p.75

S. Quijano-roy, B. Mbieleu, C. Bönnemann, P. Jeannet, J. Colomer et al., mutations cause a new form of congenital muscular dystrophy, Annals of Neurology, vol.30, issue.2, pp.177-186, 2008.
DOI : 10.1002/ana.21417

S. Shackleton, D. Lloyd, S. Jackson, R. Evans, M. Niermeijer et al., LMNA, encoding lamin A/C, is mutated in partial lipodystrophy, Nature Genetics, vol.112, issue.2, pp.153-156, 2000.
DOI : 10.1038/72807

G. Novelli, A. Muchir, F. Sangiuolo, A. Helbling-leclerc, D. Apice et al., Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C, The American Journal of Human Genetics, vol.71, issue.2, pp.426-431, 2002.
DOI : 10.1086/341908

F. Caux, E. Dubosclard, O. Lascols, B. Buendia, O. Chazouillères et al., A New Clinical Condition Linked to a Novel Mutation in Lamins A and C with Generalized Lipoatrophy, Insulin-Resistant Diabetes, Disseminated Leukomelanodermic Papules, Liver Steatosis, and Cardiomyopathy, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1006-1013, 2003.
DOI : 10.1210/jc.2002-021506

M. Eriksson, W. Brown, L. Gordon, M. Glynn, J. Singer et al., Recurrent de novo point mutations in lamin A cause Hutchinson???Gilford progeria syndrome, Nature, vol.111, issue.6937, pp.293-298, 2003.
DOI : 10.1086/302836

C. Navarro, D. Sandre-giovannoli, A. Bernard, R. Boccaccio, I. Boyer et al., Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy, Human Molecular Genetics, vol.13, issue.20, pp.2493-2503, 2004.
DOI : 10.1093/hmg/ddh265

L. Chen, L. Lee, B. Kudlow, D. Santos, H. Sletvold et al., LMNA mutations in atypical Werner's syndrome, The Lancet, vol.362, issue.9382, pp.440-445, 2003.
DOI : 10.1016/S0140-6736(03)14069-X

F. Caux, E. Dubosclard, O. Lascols, B. Buendia, O. Chazouillères et al., A New Clinical Condition Linked to a Novel Mutation in Lamins A and C with Generalized Lipoatrophy, Insulin-Resistant Diabetes, Disseminated Leukomelanodermic Papules, Liver Steatosis, and Cardiomyopathy, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1006-1013, 2003.
DOI : 10.1210/jc.2002-021506

D. Sandre-giovannoli, A. Chaouch, M. Kozlov, S. Vallat, J. Tazir et al., Homozygous Defects in LMNA, Encoding Lamin A/C Nuclear-Envelope Proteins, Cause Autosomal Recessive Axonal Neuropathy in Human (Charcot-Marie-Tooth Disorder Type 2) and Mouse, The American Journal of Human Genetics, vol.70, issue.3, pp.726-736, 2002.
DOI : 10.1086/339274

W. Dauer and H. Worman, The Nuclear Envelope as a Signaling Node in Development and Disease, Developmental Cell, vol.17, issue.5, pp.626-638, 2009.
DOI : 10.1016/j.devcel.2009.10.016

C. Navarro, P. Cau, and N. Lévy, Molecular bases of progeroid syndromes, Human Molecular Genetics, vol.15, issue.Review Issue 2, pp.151-161, 2006.
DOI : 10.1093/hmg/ddl214

A. Bertrand, K. Chikhaoui, B. Yaou, R. Bonne, and G. , Laminopathies : un seul g??ne, de nombreuses pathologies, Biologie Aujourd'hui, vol.205, issue.3, pp.147-162, 2011.
DOI : 10.1051/jbio/2011017

R. Hershberger, S. Parks, J. Kushner, D. Li, S. Ludwigsen et al., Coding Sequence Mutations Identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 Patients with Familial or Idiopathic Dilated Cardiomyopathy, Clinical and Translational Science, vol.88, issue.1, pp.21-26, 2008.
DOI : 10.1016/S0092-8674(01)00242-2

R. Hershberger, N. Norton, A. Morales, D. Li, J. Siegfried et al., Coding Sequence Rare Variants Identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 From 312 Patients With Familial or Idiopathic Dilated Cardiomyopathy, Circulation: Cardiovascular Genetics, vol.3, issue.2, pp.155-161, 2010.
DOI : 10.1161/CIRCGENETICS.109.912345

R. Hershberger, J. Lindenfeld, L. Mestroni, C. Seidman, M. Taylor et al., Genetic Evaluation of Cardiomyopathy???A Heart Failure Society of America Practice Guideline, Journal of Cardiac Failure, vol.15, issue.2, pp.83-97, 2009.
DOI : 10.1016/j.cardfail.2009.01.006

N. Lakdawala, B. Funke, S. Baxter, A. Cirino, A. Roberts et al., Genetic Testing for Dilated Cardiomyopathy in Clinical Practice, Journal of Cardiac Failure, vol.18, issue.4, pp.296-303, 2012.
DOI : 10.1016/j.cardfail.2012.01.013

R. Hershberger and J. Siegfried, Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy, Journal of the American College of Cardiology, vol.57, issue.16, pp.1641-1649, 2011.
DOI : 10.1016/j.jacc.2011.01.015

L. Mestroni, C. Rocco, D. Gregori, G. Sinagra, D. Lenarda et al., Familial dilated cardiomyopathy, Journal of the American College of Cardiology, vol.34, issue.1, pp.181-190, 1999.
DOI : 10.1016/S0735-1097(99)00172-2

N. Lakdawala and M. Givertz, Dilated Cardiomyopathy With Conduction Disease and Arrhythmia. Circulation. 2 août 2010, pp.527-534

J. Van-tintelen, R. Hofstra, H. Katerberg, T. Rossenbacker, A. Wiesfeld et al., High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics, American Heart Journal, vol.154, issue.6, pp.1130-1139, 2007.
DOI : 10.1016/j.ahj.2007.07.038

S. Parks, J. Kushner, D. Nauman, D. Burgess, S. Ludwigsen et al., Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy, American Heart Journal, vol.156, issue.1, pp.161-169, 2008.
DOI : 10.1016/j.ahj.2008.01.026

A. Perrot, S. Hussein, V. Ruppert, H. Schmidt, M. Wehnert et al., Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy, Basic Research in Cardiology, vol.313, issue.1, pp.90-99, 2009.
DOI : 10.1007/s00395-008-0748-6

G. Millat, P. Bouvagnet, C. P. Sebbag, L. Dulac, A. Dauphin et al., Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy, European Journal of Medical Genetics, vol.54, issue.6, pp.570-575, 2011.
DOI : 10.1016/j.ejmg.2011.07.005

URL : https://hal.archives-ouvertes.fr/hal-01017144

D. Herman, L. Lam, M. Taylor, L. Wang, P. Teekakirikul et al., Truncations of Titin Causing Dilated Cardiomyopathy, New England Journal of Medicine, vol.366, issue.7, pp.619-628, 2012.
DOI : 10.1056/NEJMoa1110186

E. Arbustini, A. Pilotto, A. Repetto, M. Grasso, A. Negri et al., Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease, Journal of the American College of Cardiology, vol.39, issue.6, pp.981-990, 2002.
DOI : 10.1016/S0735-1097(02)01724-2

N. Lakdawala, J. Winterfield, and B. Funke, Dilated Cardiomyopathy, Circulation: Arrhythmia and Electrophysiology, vol.6, issue.1, pp.228-237, 2013.
DOI : 10.1161/CIRCEP.111.962050

J. Van-berlo, D. Duboc, and Y. Pinto, Often seen but rarely recognised: cardiac complications of lamin A/C mutations, European Heart Journal, vol.25, issue.10, pp.812-814, 2004.
DOI : 10.1016/j.ehj.2004.03.007

J. Otomo, S. Kure, T. Shiba, A. Karibe, T. Shinozaki et al., Electrophysiological and Histopathological Characteristics of Progressive Atrioventricular Block Accompanied by Familial Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene, Journal of Cardiovascular Electrophysiology, vol.97, issue.2, pp.137-145, 2005.
DOI : 10.1038/12618

T. Marshall and V. Huckell, Atrial Paralysis in a Patient with Emery-Dreifuss Muscular Dystrophy, Pacing and Clinical Electrophysiology, vol.14, issue.2, pp.135-140, 1992.
DOI : 10.1016/0002-9343(65)90059-8

G. Boriani, M. Gallina, L. Merlini, G. Bonne, D. Toniolo et al., Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy: A Long-Term Longitudinal Study, Stroke, vol.34, issue.4, pp.901-908, 2003.
DOI : 10.1161/01.STR.0000064322.47667.49

I. Van-rijsingen, A. Bakker, D. Azim, J. Hermans-van-ast, A. Van-der-kooi et al., Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications, International Journal of Cardiology, vol.168, issue.1, 2012.
DOI : 10.1016/j.ijcard.2012.09.118

K. Brauch, L. Chen, and T. Olson, Comprehensive Mutation Scanning of LMNA in 268 Patients With Lone Atrial Fibrillation, The American Journal of Cardiology, vol.103, issue.10, pp.1426-1428, 2009.
DOI : 10.1016/j.amjcard.2009.01.354

N. Marrouche, D. Wilber, G. Hindricks, P. Jais, N. Akoum et al., Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation, JAMA, vol.311, issue.5, pp.498-506, 2014.
DOI : 10.1001/jama.2014.3

C. Mcgann, N. Akoum, A. Patel, E. Kholmovski, P. Revelo et al., Atrial Fibrillation Ablation Outcome Is Predicted by Left Atrial Remodeling on MRI, Circulation: Arrhythmia and Electrophysiology, vol.7, issue.1, 2013.
DOI : 10.1161/CIRCEP.113.000689

R. Frock, S. Chen, D. Da, E. Frett, C. Lau et al., Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna???/??? Mice, PLoS ONE, vol.7, issue.8, p.42918, 2012.
DOI : 10.1371/journal.pone.0042918.s006

J. Van-tintelen, R. Tio, W. Kerstjens-frederikse, J. Van-berlo, L. Boven et al., Severe Myocardial Fibrosis Caused by a Deletion of the 5??? End of the Lamin A/C Gene, Journal of the American College of Cardiology, vol.49, issue.25, pp.2430-2439, 2007.
DOI : 10.1016/j.jacc.2007.02.063

M. Holmström, S. Kivistö, T. Heliö, R. Jurkko, M. Kaartinen et al., Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy, Journal of Cardiovascular Magnetic Resonance, vol.13, issue.1, p.30, 2011.
DOI : 10.1016/j.echo.2008.07.016

J. Mccrohon, J. Moon, S. Prasad, W. Mckenna, C. Lorenz et al., Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance, Circulation, vol.108, issue.1, pp.54-59, 2003.
DOI : 10.1161/01.CIR.0000078641.19365.4C

R. Assomull, S. Prasad, J. Lyne, G. Smith, E. Burman et al., Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy, Journal of the American College of Cardiology, vol.48, issue.10, 1977.
DOI : 10.1016/j.jacc.2006.07.049

W. Mcnair, L. Ku, M. Taylor, P. Fain, D. Dao et al., SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia, Circulation, vol.110, issue.15, pp.2163-2167, 2004.
DOI : 10.1161/01.CIR.0000144458.58660.BB

W. Mcnair, G. Sinagra, M. Taylor, D. Lenarda, A. Ferguson et al., SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism, Journal of the American College of Cardiology, vol.57, issue.21, pp.2160-2168, 2011.
DOI : 10.1016/j.jacc.2010.09.084

T. Olson, V. Michels, J. Ballew, S. Reyna, M. Karst et al., Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation, JAMA, vol.293, issue.4, pp.447-454, 2005.
DOI : 10.1001/jama.293.4.447

L. Mestroni, S. Miyamoto, and M. Taylor, Genetics of dilated cardiomyopathy conduction disease, Progress in Pediatric Cardiology, vol.24, issue.1, pp.3-13, 2007.
DOI : 10.1016/j.ppedcard.2007.08.003

T. Sanna, D. Russo, A. Toniolo, D. Vytopil, M. Pelargonio et al., Cardiac features of Emery???Dreifuss muscular dystrophy caused by lamin A/C gene mutations, European Heart Journal, vol.24, issue.24, pp.2227-2236, 2003.
DOI : 10.1016/j.ehj.2003.09.020

G. Bonne, E. Mercuri, A. Muchir, A. Urtizberea, H. Bécane et al., Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene, Annals of Neurology, vol.24, issue.2, pp.170-180, 2000.
DOI : 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J

N. Carboni, M. Mura, G. Marrosu, E. Cocco, S. Marini et al., gene mutations, Muscle & Nerve, vol.25, issue.4, pp.458-463, 2010.
DOI : 10.1002/mus.21514

S. Bione, E. Maestrini, S. Rivella, M. Mancini, S. Regis et al., Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy, Nature Genetics, vol.157, issue.4, pp.323-327, 1994.
DOI : 10.1038/362297a0

A. Emery and F. Dreifuss, Unusual type of benign x-linked muscular dystrophy., Journal of Neurology, Neurosurgery & Psychiatry, vol.29, issue.4, pp.338-342, 1966.
DOI : 10.1136/jnnp.29.4.338

A. Van-der-kooi, T. Ledderhof, W. De-voogt, C. Res, G. Bouwsma et al., A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement, Annals of Neurology, vol.51, issue.5, pp.636-642, 1996.
DOI : 10.1002/ana.410390513

G. Brodsky, F. Muntoni, S. Miocic, G. Sinagra, C. Sewry et al., Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement, Circulation, vol.101, issue.5, pp.473-476, 2000.
DOI : 10.1161/01.CIR.101.5.473

J. Forissier, G. Bonne, C. Bouchier, L. Duboscq-bidot, P. Richard et al., Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A/C gene mutation, European Journal of Heart Failure, vol.10, issue.6, pp.821-825, 2003.
DOI : 10.1016/S1388-9842(03)00149-1

M. Hermida-prieto, L. Monserrat, A. Castro-beiras, R. Laredo, R. Soler et al., Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations, The American Journal of Cardiology, vol.94, issue.1, pp.50-54, 2004.
DOI : 10.1016/j.amjcard.2004.03.029

B. Beckmann, E. Holinski-feder, M. Walter, N. Haserück, C. Reithmann et al., Laminopathy presenting as familial atrial fibrillation, International Journal of Cardiology, vol.145, issue.2, pp.394-396, 2010.
DOI : 10.1016/j.ijcard.2010.04.024

L. Renou, S. Stora, R. Yaou, M. Volk, M. Sinkovec et al., Heart-hand syndrome of Slovenian type: a new kind of laminopathy, Journal of Medical Genetics, vol.45, issue.10, pp.666-671, 2008.
DOI : 10.1136/jmg.2008.060020

S. Jackson, T. Howlett, P. Mcnally, O. Rahilly, S. Trembath et al., Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy, QJM, vol.90, issue.1, pp.27-36, 1997.
DOI : 10.1093/qjmed/90.1.27

M. Vantyghem, A. Balavoine, C. Douillard, F. Defrance, L. Dieudonne et al., How to diagnose a lipodystrophy syndrome, Annales d'Endocrinologie, vol.73, issue.3, pp.170-189, 2012.
DOI : 10.1016/j.ando.2012.04.010

W. Haque, E. Oral, K. Dietz, A. Bowcock, A. Agarwal et al., Risk Factors for Diabetes in Familial Partial Lipodystrophy, Dunnigan Variety, Diabetes Care, vol.26, issue.5, pp.1350-1355, 2003.
DOI : 10.2337/diacare.26.5.1350

A. Decaudain, M. Vantyghem, B. Guerci, A. Hécart, M. Auclair et al., Mutations in Patients with Severe Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4835-4844, 2007.
DOI : 10.1210/jc.2007-0654

W. Haque, I. Shimomura, Y. Matsuzawa, and A. Garg, Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.5, p.2395, 2002.
DOI : 10.1210/jcem.87.5.8624

R. Hegele, M. Kraw, M. Ban, B. Miskie, M. Huff et al., Elevated Serum C-Reactive Protein and Free Fatty Acids Among Nondiabetic Carriers of Missense Mutations in the Gene Encoding Lamin A/C (LMNA) With Partial Lipodystrophy, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.1, pp.111-116, 2003.
DOI : 10.1161/01.ATV.0000047460.27435.B8

A. Van-der-kooi, G. Bonne, B. Eymard, D. Duboc, B. Talim et al., Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy, Neurology, vol.59, issue.4, pp.620-623, 2002.
DOI : 10.1212/WNL.59.4.620

C. Vigouroux, J. Magré, M. Vantyghem, C. Bourut, O. Lascols et al., Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy, Diabetes, vol.49, issue.11, 1958.
DOI : 10.2337/diabetes.49.11.1958

D. Araújo-vilar, J. Lado-abeal, F. Palos-paz, G. Lattanzi, M. Bandín et al., A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy, Clinical Endocrinology, vol.114, issue.1, pp.61-68, 2008.
DOI : 10.1093/hmg/ddi158

L. Subramanyam, V. Simha, and A. Garg, Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations, Clinical Genetics, vol.355, issue.1, pp.66-73, 2010.
DOI : 10.1111/j.1399-0004.2009.01350.x

A. Garg, R. Speckman, and A. Bowcock, Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene, The American Journal of Medicine, vol.112, issue.7, pp.549-555, 2002.
DOI : 10.1016/S0002-9343(02)01070-7

M. Vantyghem, P. Pigny, C. Maurage, N. Rouaix-emery, T. Stojkovic et al., R482W Mutation Show Muscular and Cardiac Abnormalities, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.11, pp.5337-5346, 2004.
DOI : 10.1210/jc.2003-031658

V. Simha, L. Subramanyam, L. Szczepaniak, C. Quittner, B. Adams-huet et al., Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.3, pp.785-792, 2012.
DOI : 10.1210/jc.2011-2229

J. Park, E. Javor, E. Cochran, A. Depaoli, and P. Gorden, Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy, Metabolism, vol.56, issue.4, pp.508-516, 2007.
DOI : 10.1016/j.metabol.2006.11.010

D. Sandre-giovannoli, A. Bernard, R. Cau, P. Navarro, C. Amiel et al., Lamin A Truncation in Hutchinson-Gilford Progeria, Science, vol.300, issue.5628, p.2055, 2003.
DOI : 10.1126/science.1084125

F. Debusk, The Hutchinson-Gilford progeria syndrome, The Journal of Pediatrics, vol.80, issue.4, pp.697-724, 1972.
DOI : 10.1016/S0022-3476(72)80229-4

C. Goizet, A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia, Journal of Medical Genetics, vol.41, issue.3, pp.29-29, 2004.
DOI : 10.1136/jmg.2003.013383

R. Hegele, LMNA mutation position predicts organ system involvement in laminopathies, Clinical Genetics, vol.68, issue.1, pp.31-34, 2005.
DOI : 10.1111/j.1399-0004.2005.00447.x

N. Carboni, L. Politano, M. Floris, A. Mateddu, E. Solla et al., Overlapping syndromes in laminopathies: a meta-analysis of the reported literature Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol Ed Gaetano Conte Acad Study Striated Muscle Dis, pp.7-17, 2013.

T. Arimura, A. Helbling-leclerc, C. Massart, S. Varnous, F. Niel et al., Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies, Human Molecular Genetics, vol.14, issue.1, pp.155-169, 2005.
DOI : 10.1093/hmg/ddi017

URL : https://hal.archives-ouvertes.fr/hal-00165763

C. Hutchison, Lamins: building blocks or regulators of gene expression?, Nature Reviews Molecular Cell Biology, vol.101, issue.11, pp.848-858, 2002.
DOI : 10.1038/nrm950

N. Wiesel, A. Mattout, S. Melcer, N. Melamed-book, H. Herrmann et al., Laminopathic mutations interfere with the assembly, localization, and dynamics of nuclear lamins, Proceedings of the National Academy of Sciences, vol.105, issue.1, pp.180-185, 2008.
DOI : 10.1073/pnas.0708974105

C. Wolf, L. Wang, R. Alcalai, A. Pizard, P. Burgon et al., Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease, Journal of Molecular and Cellular Cardiology, vol.44, issue.2, pp.293-303, 2008.
DOI : 10.1016/j.yjmcc.2007.11.008

L. Mounkes, S. Kozlov, J. Rottman, and C. Stewart, Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice, Human Molecular Genetics, vol.14, issue.15, pp.2167-2180, 2005.
DOI : 10.1093/hmg/ddi221

A. Muchir, P. Pavlidis, V. Decostre, A. Herron, T. Arimura et al., Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy, Journal of Clinical Investigation, vol.117, issue.5, pp.1282-1293, 2007.
DOI : 10.1172/JCI29042

J. Choi, A. Muchir, W. Wu, S. Iwata, S. Homma et al., Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation, Science Translational Medicine, vol.4, issue.144, pp.144-102, 2012.
DOI : 10.1126/scitranslmed.3003875

A. Muchir, S. Reilly, W. Wu, S. Iwata, S. Homma et al., Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene, Cardiovascular Research, vol.93, issue.2, pp.311-319, 2012.
DOI : 10.1093/cvr/cvr301

A. Muchir, Y. Kim, S. Reilly, W. Wu, J. Choi et al., Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation. Skelet Muscle, p.17, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00842001

W. Wu, J. Shan, G. Bonne, H. Worman, and A. Muchir, Pharmacological inhibition of c-Jun Nterminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene, Biochim Biophys Acta. août, vol.1802, pp.7-8632, 2010.

A. Muchir, W. Wu, and H. Worman, Mitogen-Activated Protein Kinase Inhibitor Regulation of Heart Function and Fibrosis in Cardiomyopathy Caused by Lamin A/C Gene Mutation, Trends in Cardiovascular Medicine, vol.20, issue.7, pp.217-221, 2010.
DOI : 10.1016/j.tcm.2011.11.002

W. Wu, A. Muchir, J. Shan, G. Bonne, and H. Worman, Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene, Circulation, vol.123, issue.1, pp.53-61, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.970673

J. Van-berlo, J. Voncken, N. Kubben, J. Broers, R. Duisters et al., A-type lamins are essential for TGF-??1 induced PP2A to dephosphorylate transcription factors, Human Molecular Genetics, vol.14, issue.19, pp.2839-2849, 2005.
DOI : 10.1093/hmg/ddi316

G. Bidault, M. Garcia, M. Vantyghem, P. Ducluzeau, R. Morichon et al., Lipodystrophy-Linked LMNA p.R482W Mutation Induces Clinical Early Atherosclerosis and In Vitro Endothelial Dysfunction, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, issue.9, pp.2162-2171, 2013.
DOI : 10.1161/ATVBAHA.113.301933

A. Garg, Acquired and Inherited Lipodystrophies, New England Journal of Medicine, vol.350, issue.12, pp.1220-1234, 2004.
DOI : 10.1056/NEJMra025261

C. Lelliott, L. Logie, C. Sewter, D. Berger, J. P. Blows et al., Lamin Expression in Human Adipose Cells in Relation to Anatomical Site and Differentiation State, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.2, pp.728-734, 2002.
DOI : 10.1210/jcem.87.2.8256

R. Hegele, Molecular basis of partial lipodystrophy and prospects for therapy, Trends in Molecular Medicine, vol.7, issue.3, pp.121-126, 2001.
DOI : 10.1016/S1471-4914(01)01930-X

S. Benedetti, I. Menditto, M. Degano, C. Rodolico, L. Merlini et al., Phenotypic clustering of lamin A/C mutations in neuromuscular patients, Neurology, vol.69, issue.12, pp.1285-1292, 2007.
DOI : 10.1212/01.wnl.0000261254.87181.80

A. Bertrand, K. Chikhaoui, R. Yaou, and G. Bonne, Clinical and genetic heterogeneity in laminopathies, Biochemical Society Transactions, vol.161, issue.6, pp.1687-1692, 2011.
DOI : 10.1073/pnas.0402943101

I. Van-rijsingen, E. Arbustini, P. Elliott, J. Mogensen, J. Hermans-van-ast et al., Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers, Journal of the American College of Cardiology, vol.59, issue.5, pp.493-500, 2012.
DOI : 10.1016/j.jacc.2011.08.078

M. Vytopil, S. Benedetti, E. Ricci, G. Galluzzi, D. Russo et al., Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes, Journal of Medical Genetics, vol.40, issue.12, p.132, 2003.
DOI : 10.1136/jmg.40.12.e132

B. Granger, L. Gueneau, V. Drouin-garraud, V. Pedergnana, F. Gagnon et al., Modifier locus of the skeletal muscle involvement in Emery???Dreifuss muscular dystrophy, Human Genetics, vol.16, issue.Suppl 1, pp.149-159, 2011.
DOI : 10.1007/s00439-010-0909-1

I. Van-rijsingen, E. Nannenberg, E. Arbustini, P. Elliott, J. Mogensen et al., Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers, European Journal of Heart Failure, vol.7, issue.4, pp.376-384, 2013.
DOI : 10.1093/eurjhf/hfs191

N. Hasselberg, T. Edvardsen, H. Petri, K. Berge, T. Leren et al., Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol, 2013.

F. Anselme, G. Moubarak, A. Savouré, B. Godin, B. Borz et al., Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders, Heart Rhythm, vol.10, issue.10
DOI : 10.1016/j.hrthm.2013.06.020

A. Garg and . Lipodystrophies, Lipodystrophies, The American Journal of Medicine, vol.108, issue.2, pp.143-152, 2000.
DOI : 10.1016/S0002-9343(99)00414-3

A. Garg, M. Vinaitheerthan, P. Weatherall, and A. Bowcock, Phenotypic Heterogeneity in Patients with Familial Partial Lipodystrophy (Dunnigan Variety) Related to the Site of Missense Mutations in Lamin A/C Gene, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.1, pp.59-65, 2001.
DOI : 10.1210/jc.86.1.59

P. Mory, F. Crispim, M. Freire, J. Salles, C. Valério et al., Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations, European Journal of Endocrinology, vol.167, issue.3, pp.423-431, 2012.
DOI : 10.1530/EJE-12-0268

E. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar et al., Leptin-Replacement Therapy for Lipodystrophy, New England Journal of Medicine, vol.346, issue.8, pp.570-578, 2002.
DOI : 10.1056/NEJMoa012437

A. Van-der-kooi, G. Bonne, B. Eymard, D. Duboc, B. Talim et al., Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy, Neurology, vol.59, issue.4, pp.620-623, 2002.
DOI : 10.1212/WNL.59.4.620

K. Wiltshire, R. Hegele, A. Innes, and A. Brownell, Homozygous Lamin A/C familial lipodystrophy R482Q mutation in autosomal recessive Emery Dreifuss muscular dystrophy, Neuromuscular Disorders, vol.23, issue.3, pp.265-268, 2013.
DOI : 10.1016/j.nmd.2012.11.011

J. Broers, E. Peeters, H. Kuijpers, J. Endert, C. Bouten et al., Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies, Human Molecular Genetics, vol.13, issue.21, pp.2567-2580, 2004.
DOI : 10.1093/hmg/ddh295

J. Lammerding, P. Schulze, T. Takahashi, S. Kozlov, T. Sullivan et al., Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction, Journal of Clinical Investigation, vol.113, issue.3, pp.370-378, 2004.
DOI : 10.1172/JCI200419670

B. Davies, R. Barnes, Y. Tu, S. Ren, D. Andres et al., An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria, Human Molecular Genetics, vol.19, issue.13, pp.2682-2694, 2010.
DOI : 10.1093/hmg/ddq158

L. Fong, J. Ng, J. Lammerding, T. Vickers, M. M. Coté et al., Prelamin A and lamin A appear to be dispensable in the nuclear lamina, Journal of Clinical Investigation, vol.116, issue.3, pp.743-752, 2006.
DOI : 10.1172/JCI27125

D. Sandre-giovannoli, A. Bernard, R. Cau, P. Navarro, C. Amiel et al., Lamin A Truncation in Hutchinson-Gilford Progeria, Science, vol.300, issue.5628, p.2055, 2003.
DOI : 10.1126/science.1084125

D. Zipes, A. Camm, M. Borggrefe, and A. Buxton, ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, European Heart Rhythm Association, pp.247-346, 2006.
DOI : 10.1016/j.jacc.2006.07.010

A. Barsheshet, A. Moss, S. Mcnitt, C. Jons, M. Glikson et al., Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator, Heart Rhythm, vol.8, issue.2, pp.212-218, 2011.
DOI : 10.1016/j.hrthm.2010.10.035

J. Steinberg, A. Fischer, P. Wang, C. Schuger, J. Daubert et al., The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II, Journal of Cardiovascular Electrophysiology, vol.1, issue.4, pp.359-365, 2005.
DOI : 10.1046/j.1540-8167.2005.50038.x

M. Zecchin, D. Lenarda, A. Gregori, D. Merlo, M. Pivetta et al., Are Nonsustained Ventricular Tachycardias Predictive of Major Arrhythmias in Patients with Dilated Cardiomyopathy on Optimal Medical Treatment?, Pacing and Clinical Electrophysiology, vol.101, issue.3, pp.290-299, 2008.
DOI : 10.1161/hc3101.093906

L. Iles, H. Pfluger, L. Lefkovits, M. Butler, P. Kistler et al., Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death, Journal of the American College of Cardiology, vol.57, issue.7, pp.821-828, 2011.
DOI : 10.1016/j.jacc.2010.06.062

M. Baig, J. Goldman, A. Caforio, A. Coonar, P. Keeling et al., Familial Dilated Cardiomyopathy: Cardiac Abnormalities Are Common in Asymptomatic Relatives and May Represent Early Disease, Journal of the American College of Cardiology, vol.31, issue.1, pp.195-201, 1998.
DOI : 10.1016/S0735-1097(97)00433-6

M. Ackerman, S. Priori, S. Willems, C. Berul, R. Brugada et al., HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, vol.13, issue.8, pp.1308-1339, 2011.
DOI : 10.1093/europace/eur245

N. Maraldi, C. Capanni, E. Mattioli, M. Columbaro, S. Squarzoni et al., A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome, Acta Bio-Medica Atenei Parm, vol.78, issue.1, pp.207-215, 2007.

E. Arioglu, J. Duncan-morin, N. Sebring, K. Rother, N. Gottlieb et al., Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes, Annals of Internal Medicine, vol.133, issue.4, pp.263-274, 2000.
DOI : 10.7326/0003-4819-133-4-200008150-00009

I. Varela, S. Pereira, A. Ugalde, C. Navarro, M. Suárez et al., Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging, Nature Medicine, vol.154, issue.7, pp.767-772, 2008.
DOI : 10.1038/nm1786

URL : https://hal.archives-ouvertes.fr/inserm-00376425

. Je-ne-tromperai-jamais-leur-confiance, Je donnerai mes soins à l'indigent et je n'exigerai pas un salaire au dessus de mon travail